XML 22 R5.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENT OF CASH FLOW
¥ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
USD ($)
Dec. 31, 2020
CNY (¥)
Dec. 31, 2019
CNY (¥)
Dec. 31, 2018
CNY (¥)
CONSOLIDATED STATEMENT OF CASH FLOW        
Net cash flows from operating activities $ 2,280,666 ¥ 14,881,346 ¥ 12,491,673 ¥ 13,021,676
Investing activities        
Purchases of property, plant and equipment (772,245) (5,038,896) (9,050,859) (6,748,212)
Purchase of other financial assets measured at fair value (1,075,862) (7,020,000) (3,500,700)  
Purchases of investment properties     (44,063)  
Purchases of intangible assets       (103,304)
Purchase of land use rights       (2,838)
Proceeds from disposal of property, plant and equipment 235,138 1,534,275 1,132,847 564,791
Proceeds from disposal of a joint venture and an associate     367,867 30,816
Proceeds from disposal of subsidiaries, net of cash 6,576 42,910 23,797  
Proceeds from disposal of other financial assets measured at fair value 1,717,668 11,207,783 2,155 198,000
Proceeds from disposal of intangible assets 42,562 277,715 5,764  
Proceeds from disposal of right-of-use assets 2,317 15,118    
Proceeds from disposal and deemed disposal of subsidiaries and business, net of cash       6,558
Investments in joint ventures (664) (4,333) (50,000) (90,000)
Investments in associates (1,145) (7,473) (2,653,244) (266,300)
Dividend from other financial assets measured at fair value 12,689 82,794 97,775 109,914
Dividends received from associates and joint ventures 49,519 323,109 236,708 327,983
Change in deposit of futures contracts (8,606) (56,156) (67,253) (13,288)
Asset-related government grants received 7,289 47,558 103,373 167,314
Investment income from other financial assets measured at fair value 80,418 524,726    
Loans repaid by related parties       32,215
Proceeds from acquisition of subsidiaries, net of cash 566 3,690   255,650
Net cash flows (used in)/generated from investing activities 296,220 1,932,820 (13,395,833) (5,530,701)
Financing activities        
Repayments of short-term bonds and mid-term notes (4,695,604) (30,638,813) (22,400,000) (21,815,000)
Repayments of short-term and long-term bank borrowings and other loans (6,607,120) (43,111,460) (66,105,388) (70,560,667)
Repayments of gold leasing arrangement (1,060,821) (6,921,860) (1,607,905) (7,519,283)
Cash consideration paid for business combination under common control     (237) (373,495)
Proceeds from a gold leasing arrangement     6,921,860 2,323,105
Proceeds from issuance of short-term bonds and medium-term notes 3,969,349 25,900,000 37,974,402 13,185,034
Proceeds from sale and leaseback finance leases, net of deposit and transaction costs       1,204,843
Drawdown of short-term and long-term bank borrowings and other loans 7,053,089 46,021,404 40,669,197 76,899,591
Senior perpetual securities' distribution paid (64,585) (421,416) (352,648) (410,548)
Capital injection from non-controlling shareholders 30,234 197,276 711,114 837,621
Capital injection from the parent company to the entity acquired under common control       69,885
Share issue cost     (51,678)  
Principal portion of lease payments (267,924) (1,748,202) (3,032,106)  
Finance lease instalment paid       (3,915,404)
Dividends paid by subsidiaries to non-controlling shareholders (54,611) (356,340) (222,930) (327,645)
Interest paid (561,644) (3,664,725) (4,467,803) (5,445,120)
Repayments of senior perpetual securities (306,513) (2,000,000)   (2,417,758)
Purchase of non-controlling interests       (3,765)
Instalment payment of bonds issuance expenses (4,488) (29,285) (9,913)  
Proceeds from issuance of perpetual securities 153,257 1,000,000 1,500,000 1,988,000
Net cash flows used in financing activities (2,417,381) (15,773,421) (10,474,035) (16,280,606)
Net increase/(decrease) in cash and cash equivalents 159,505 1,040,745 (11,378,195) (8,789,631)
Cash and cash equivalents at beginning of year 1,192,161 7,778,853 19,135,843 27,868,110
Effect of foreign exchange rate changes, net (13,548) (88,401) 21,205 57,364
Cash and cash equivalents at December 31 $ 1,338,118 ¥ 8,731,197 ¥ 7,778,853 ¥ 19,135,843